Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis

医学 荟萃分析 随机对照试验 化疗所致周围神经病变 内科学 物理疗法 心理干预 严格标准化平均差 不利影响 科克伦图书馆 置信区间 周围神经病变 精神科 糖尿病 内分泌学
作者
Megan Crichton,Patsy Yates,Oluwaseyifunmi Andi Agbejule,A. Spooner,Raymond J. Chan,Nicolas H. Hart
出处
期刊:Nutrients [Multidisciplinary Digital Publishing Institute]
卷期号:14 (12): 2403-2403 被引量:9
标识
DOI:10.3390/nu14122403
摘要

Non-pharmacological self-management interventions for chemotherapy-induced peripheral neurotherapy (CIPN) are of clinical interest; however, no systematic review has synthesized the evidence for their use in people with advanced cancer. Five databases were searched from inception to February 2022 for randomized controlled trials assessing the effect of non-pharmacological self-management interventions in people with advanced cancer on the incidence and severity of CIPN symptoms and related outcomes compared to any control condition. Data were pooled with meta-analysis. Quality of evidence was appraised using the Revised Cochrane Risk of Bias Tool for Randomized Trials (RoB2), with data synthesized narratively. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) was applied to assess the certainty of the evidence. Thirteen studies were included, which had a high (69%) or unclear (31%) risk of bias. Greatest confidence was found for physical exercise decreasing CIPN severity (SMD: −0.89, 95% CI: −1.37 to −0.41; p = 0.0003; I2 = 0%; n = 2 studies, n = 76 participants; GRADE level: moderate) and increasing physical function (SMD: 0.51, 95% CI: 0.02 to 1.00; p = 0.04; I2 = 42%; n = 3 studies, n = 120; GRADE level: moderate). One study per intervention provided preliminary evidence for the positive effects of glutamine supplementation, an Omega-3 PUFA-enriched drink, and education for symptom self-management via a mobile phone game on CIPN symptoms and related outcomes (GRADE: very low). No serious adverse events were reported. The strongest evidence with the most certainty was found for physical exercise as a safe and viable adjuvant to chemotherapy treatment for the prevention and management of CIPN and related physical function in people with advanced cancer. However, the confidence in the evidence to inform conclusions was mostly very low to moderate. Future well-powered and appropriately designed interventions for clinical trials using validated outcome measures and clearly defined populations and strategies are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏应助大力绿柏采纳,获得10
1秒前
1秒前
ri_290完成签到 ,获得积分10
2秒前
贾克斯发布了新的文献求助10
2秒前
何处芳歇发布了新的文献求助10
2秒前
小当家完成签到,获得积分10
2秒前
nightmare发布了新的文献求助10
3秒前
Ava应助独特乘云采纳,获得10
5秒前
义气黄焖排骨完成签到,获得积分10
5秒前
古藤完成签到 ,获得积分10
6秒前
shinian完成签到 ,获得积分10
6秒前
JamesPei应助nightmare采纳,获得10
7秒前
8秒前
9秒前
十年完成签到 ,获得积分10
10秒前
wwl发布了新的文献求助10
12秒前
13秒前
默默千亦完成签到 ,获得积分10
13秒前
贾克斯发布了新的文献求助10
14秒前
撸撸大仙完成签到,获得积分20
15秒前
打我呀发布了新的文献求助10
15秒前
16秒前
Jasper应助体贴的之卉采纳,获得10
17秒前
18秒前
18秒前
19秒前
ScholarZmm完成签到,获得积分10
20秒前
21秒前
22秒前
hzx发布了新的文献求助10
22秒前
22秒前
24秒前
saisyo发布了新的文献求助10
24秒前
24秒前
田様应助不发SCI不改名采纳,获得10
25秒前
幸福大白发布了新的文献求助30
26秒前
GS11发布了新的文献求助10
26秒前
Nitr0ce1L发布了新的文献求助10
27秒前
28秒前
Condor完成签到,获得积分10
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989406
求助须知:如何正确求助?哪些是违规求助? 3531522
关于积分的说明 11254187
捐赠科研通 3270174
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174